Type 2 Diabetes Mellitus Clinical Trial
Official title:
The Effects of Mixed Herbs on Blood Glucose and Lipid Profile of Patients With Established Type II Diabetes Mellitus
The aim of this study was to evaluate the effects of mixed herbs as ad-on therapy on blood sugar and lipid profile of patients with established T2DM. A total 20 patients were consented and were equally divided into the Control and the Test groups and was fed with the Placebo or mixed herbs 4 g daily for 30 days, respectively. Blood samples were collected before and at the end of the feeding period and analyzed for the parameters namely Fasting Blood Sugar (FBS), 2 hours post prandial (2HPP) Glycosylated Hb (HbA1c) and Lipid Profile. The collected data was analyzed using SPSS Statistical Software version 12.
INTRODUCTION Diabetes mellitus is a group of metabolic diseases characterized by
hyperglycemia resulting from defects in insulin secretion, insulin action, or both[1].
Symptoms of marked hyperglycemia include polyuria, polydipsia, weight loss, sometimes with
polyphagia, and blurred vision. Impairment of growth and susceptibility to certain
infections may also accompany chronic hyperglycemia[ 2]. Several pathogenic processes are
involved in the development of diabetes. These range from autoimmune destruction of the
β-cells of the pancreas with consequent insulin deficiency to abnormalities that result in
resistance to insulin action . Patients with diabetes have an increased incidence of
atherosclerotic cardiovascular, peripheral arterial, and cerebrovascular disease.
Hypertension and abnormalities of lipoprotein metabolism are often found in people with
diabetes[3].
The vast majority of cases of diabetes fall into two broad etiopathogenetic categories
called type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus . In T1DM, the cause is
an absolute deficiency of insulin secretion. In the other, much more prevalent category,
T2DM, the cause is a combination of resistance to insulin action and an inadequate
compensatory insulin secretory response [4].
Despite considerable progress in the treatment of diabetes mellitus, it's prevalence is
rising globally in an exponential rate to an extent that it is now the most severe pandemic
of the 21st century. World Health Organization (WHO) estimated that the prevalence of
diabetes for all age-groups worldwide, will increase from 2.8% in 2000 to 4.4% in 2030
whereby the total number of people with diabetes is projected to rise from 171 million in
2000, to 366 million in 2030[5].
Conventionally, insulin-dependent diabetes mellitus is treated with exogenous insulin and
non insulin-dependent diabetes mellitus with synthetic oral hypoglycemic agents (OHA) like
sulphonylureas and biguanides [6,7].Insulin therapy affords glycemic control in type 1
diabetes, yet its shortcomings such as ineffectiveness on oral administration, short shelf
life, the requirement of constant refrigeration, fatal hypoglycemia in event of excess
dosage, reluctance of patients to take insulin injection and above all, the development of
resistance due to prolonged administration, limits its usage[8]. Similarly, treatment of
T2DM patients with sulfonylureas and biguanides, is also associated with side effects [9].
For various reasons in recent years, the popularity of alternative medicine has increased.
Surveys conducted in Australia and United States indicate that almost 48.5% and 34% of the
respondents in the respective countries, had used at least one form of unconventional
therapy, including herbal medicine[10].Natural materials like herbs and spices today seem to
be used widely as traditional remedies for certain diseases. Spices which are added, during
preparation of foods, for taste and aroma have been shown to be effective in the control of
hyperglycemia both in animals and human studies[11]. Several studies conducted throughout
the world, recognized the blood glucose lowering effects of herbs and spices both in animals
as well as in human beings. Bunching Onion is a flavor and taste enhancer and contains many
health promoting compounds that can lower, low density lipoprotein cholesterol (LDL-c) and
raise high density lipoprotein cholesterol (HDL-c) level, prevent cancer, and stabilize
blood sugar levels[12]. Similarly Holy Basil contains an essential oil that possesses
antibacterial, antioxidant, anti-inflammatory and immune modulating effects, as well as
blood sugar lowering properties in diabetic patients . Curry Leaves is an inhibitor of
pancreatic enzyme α-amylase. This enzyme degrades starch to glucose in the gastrointestinal
tract, which is then released to the blood stream. So by inhibiting the α-amylase enzyme,
the leaves are able to prevent the degradation of starches to simple sugar (glucose), thus
helping to control the hyperglycemia in patients with T2DM[13]. Onion (Allium cepa) is a
common vegetable. Onion bulb and leaves are part of diet. Ether soluble fraction of onion
(0.25mg/kg, orally) has been observed to lower blood sugar level in normal rabbits and
exhibited potent antioxidant activity[14]. In a clinical study, treatment of diabetic
patients by juice of Allium cepa bulb, controlled the blood sugar level[15].
Dipropyl-disulphideoxide and onion oil produced significant hypoglycemic effect[16]. A
sulphur containing amino acid, S-methyl-cystein-sulphoxide (at a dose of 200mg/kg for 45
days) from onion showed a potent hypoglycemic activity in alloxan induced diabetic rats[17].
S-allyl-cystein-sulphoxide from onion significantly reduced blood glucose level of alloxan
induced diabetic rats[18]. Prolonged administration of freeze dried onion powder (3%) with a
diet produced anti-hyperglycemic, hypolipidemic and antioxidant activity in STZ diabetic
rats[19]. Allium cepa juice (0.4g/100g for 4 weeks) exhibited anti-hyperglycemic and
antioxidant effect in alloxan induced diabetic rats, it also repaired hepatic and renal
damage caused by alloxan[20].Coriander has been used for many years to lower blood glucose
in traditional herbal medicine. It has been reported that streptozotocin induced diabetic
mice were fed with coriander in feed or drinking water caused a significant reduction in
blood glucose[21].The anti-diabetic, hypolipidaemic and antioxidant activities of aniseeds
(star anise) and coriander seeds were compared in T2DM patients. The seed powders (5 g/day)
were administered to two groups of T2DM patients for 60 days. The results indicated 36%
decrease in fasting blood glucose in aniseed treated, and 13%decrease in coriander treated
T2DM patients, while 11% rise of fasting blood glucose in the control group. Significant
decrease in serum cholesterol and triglycerides in aniseed treated and coriander seed
treated patients was also observed. Both seeds have anti diabetic, hypolipidemic and
antioxidant effects in diabetic patients[22].
Methodology This study was conducted at Medical Out Patient Department (M-OPD), HTAA,
Kuantan, and Department of Nutrition Sciences, Kulliyyah of Allied Health Sciences,
International Islamic University Malaysia (IIUM), Kuantan.
In the present study, 20 patients of T2DM were recruited from the M-OPD, HTAA, Kuantan; and
equally divided into the control and the test groups. These patients were either fed with
placebo (maize starch) or 4 g daily mixed herbs (on wet weight basis). Informed consent was
obtained from all patients. This study was submitted to the Kulliyyah Postgraduate and
Research Committee (KPGRC) for approval and subsequently to the IIUM Research Ethics
Committee (IREC) and Clinical Research Committee (CRC).
The four types of herbs namely, coriander leaves (Coriandrum sativum), bunching onion
(Alliumfistulosum L.), curry leaves (Murraya koenigii), and holy basil leaves (Ocimum
tenuiflorum, also known as Ocimum sanctum), purchased from the local market/supplier, and
thoroughly cleaned. These were then weighed and freeze-dried, weighed again and the weight
loss was determined. The freeze dried herbs were ground with coffee mill and appropriate
amounts were encapsulated to be offered to the patients. The consumption of the capsules was
spread over the day and the numbers of capsules to be consumed per day were tailored to 4 g
of wet herbs. The total duration of the trial was 30 days.
The herbs used in the trial,are not new to the patients, as each one is being used among all
the communities in Malaysia for decades in preparation of their food daily, the only thing
new was to observe the dose effects of these on the blood sugar and lipid profile of T2DM
patients.
Data Collection All the patients were requested to provide the blood samples on Day 0, and
Day 31, for the analysis of various parameters, to assess the possible effects induced by
the consumption of mixed herbs.
Blood Sample Analysis The blood sample collected was immediately processed and analyzed at
Biochemistry Laboratory of HTAA, for FBS, 2HPP, HbA1c, and lipid profile using appropriate
kits respectively.
Statistical Analysis The current study design was Quasi-experimental study design on
registered T2DM patients. Two-way ANOVA was used for statistical analysis. Furthermore, the
data was expressed as mean ± SD and the difference in the means was ascertained at 95 %
confidence interval (P<0.05).
;
Observational Model: Case Control, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02771093 -
An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus
|
Phase 4 | |
| Completed |
NCT02545842 -
Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)
|
Phase 4 | |
| Recruiting |
NCT03436212 -
Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.
|
N/A | |
| Completed |
NCT03244800 -
A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
|
Phase 2 | |
| Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
| Withdrawn |
NCT02769091 -
A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes
|
Phase 2 | |
| Recruiting |
NCT06065540 -
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
|
Phase 3 | |
| Recruiting |
NCT05008276 -
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
|
||
| Completed |
NCT04091373 -
A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide
|
Phase 1 | |
| Completed |
NCT03296800 -
Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects
|
Phase 1 | |
| Recruiting |
NCT06212778 -
Relationship Between Nutritional Status, Hand Grip Strength, and Fatigue in Hospitalized Older Adults With Type 2 Diabetes Mellitus.
|
||
| Completed |
NCT05979519 -
Fresh Carts for Mom's to Improve Food Security and Glucose Management
|
N/A | |
| Recruiting |
NCT05579314 -
XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
| Terminated |
NCT03684642 -
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
|
Phase 3 | |
| Completed |
NCT03248401 -
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
|
Phase 4 | |
| Completed |
NCT03644134 -
A Personalized Intervention to Manage Physiological Stress and Improve Sleep Patterns
|
N/A | |
| Completed |
NCT05295160 -
Fasting-Associated Immune-metabolic Remission of Diabetes
|
N/A | |
| Completed |
NCT02836873 -
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
|
Phase 3 | |
| Completed |
NCT02226003 -
Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)
|
Phase 3 |